Xi-Xun Du1, Hua-Min Xu, Hong Jiang, Ning Song, Jun Wang, Jun-Xia Xie. 1. Department of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Dis-orders and State Key Disciplines: Physiology, Medical College of Qingdao University, Qingdao 266071, China.
Abstract
OBJECTIVE: Curcumin is a plant polyphenolic compound and a major component of spice turmeric (Curcuma longa). It has been reported to possess free radical-scavenging, iron-chelating, and anti-inflammatory properties in different tissues. Our previous study showed that curcumin protects MES23.5 dopaminergic cells from 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in vitro. The present study aimed to explore this neuroprotective effect in the 6-OHDA-lesioned rat model of Parkinson's disease in vivo. METHODS: Rats were given intragastric curcumin for 24 days. 6-OHDA lesioning was conducted on day 4 of curcumin treatment. Dopamine content was assessed by high-performance liquid chromatography with electrochemical detection, tyrosine hydroxylase (TH)-containing neurons by immunohistochemistry, and iron-containing cells by Perls' iron staining. RESULTS: The dopamine content in the striatum and the number of TH-immunoreactive neurons decreased after 6-OHDA treatment. Curcumin pretreatment reversed these changes. Further studies demonstrated that 6-OHDA treatment increased the number of iron-staining cells, which was dramatically decreased by curcumin pretreatment. CONCLUSION: The protective effects of curcumin against 6-OHDA may be attributable to the iron-chelating activity of curcumin to suppress the iron-induced degeneration of nigral dopaminergic neurons.
OBJECTIVE:Curcumin is a plant polyphenolic compound and a major component of spice turmeric (Curcuma longa). It has been reported to possess free radical-scavenging, iron-chelating, and anti-inflammatory properties in different tissues. Our previous study showed that curcumin protects MES23.5 dopaminergic cells from 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in vitro. The present study aimed to explore this neuroprotective effect in the 6-OHDA-lesioned rat model of Parkinson's disease in vivo. METHODS:Rats were given intragastric curcumin for 24 days. 6-OHDA lesioning was conducted on day 4 of curcumin treatment. Dopamine content was assessed by high-performance liquid chromatography with electrochemical detection, tyrosine hydroxylase (TH)-containing neurons by immunohistochemistry, and iron-containing cells by Perls' iron staining. RESULTS: The dopamine content in the striatum and the number of TH-immunoreactive neurons decreased after 6-OHDA treatment. Curcumin pretreatment reversed these changes. Further studies demonstrated that 6-OHDA treatment increased the number of iron-staining cells, which was dramatically decreased by curcumin pretreatment. CONCLUSION: The protective effects of curcumin against 6-OHDA may be attributable to the iron-chelating activity of curcumin to suppress the iron-induced degeneration of nigral dopaminergic neurons.
Authors: Wassilios Meissner; Michael P Hill; François Tison; Christian E Gross; Erwan Bezard Journal: Trends Pharmacol Sci Date: 2004-05 Impact factor: 14.819
Authors: Thore Santel; Gabi Pflug; Nasr Y A Hemdan; Angelika Schäfer; Marcus Hollenbach; Martin Buchold; Anja Hintersdorf; Inge Lindner; Andreas Otto; Marina Bigl; Ilka Oerlecke; Antje Hutschenreuther; Antje Hutschenreuter; Ulrich Sack; Klaus Huse; Marco Groth; Claudia Birkemeyer; Wolfgang Schellenberger; Rolf Gebhardt; Mathias Platzer; Thomas Weiss; Mookambeswaran A Vijayalakshmi; Monika Krüger; Gerd Birkenmeier Journal: PLoS One Date: 2008-10-23 Impact factor: 3.240
Authors: Sonja K Soo; Paige D Rudich; Annika Traa; Namasthée Harris-Gauthier; Hazel J Shields; Jeremy M Van Raamsdonk Journal: Mech Ageing Dev Date: 2020-06-28 Impact factor: 5.432
Authors: Pranay Srivastava; Yogesh K Dhuriya; Richa Gupta; Rajendra K Shukla; Rajesh S Yadav; Hari N Dwivedi; Aditya B Pant; Vinay K Khanna Journal: Mol Neurobiol Date: 2016-12-13 Impact factor: 5.590